|
End-of-day quote
Dhaka S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 227.60 BDT | -0.13% |
|
-4.05% | -33.39% |
| Market Cap | 6.37B 51.78M 44.44M 41.61M 38.1M 71.78M 4.95B 71.98M 493M 193M 2.49B 194M 190M 8.25B | P/E 2024 |
231x | P/E 2025 | 182x |
|---|---|---|---|---|---|
| Enterprise Value | 6.67B 54.23M 46.55M 43.58M 39.91M 75.18M 5.18B 75.39M 516M 202M 2.61B 204M 199M 8.64B | EV / Sales 2024 |
12.2x | EV / Sales 2025 | 10.1x |
| Free-Float |
59.39% | Yield 2024 |
0.25% | Yield 2025 | 0.64% |
| 1 day | -0.13% | ||
| 1 week | -4.05% | ||
| Current month | -19.60% | ||
| 1 month | -21.22% | ||
| 3 months | -26.60% | ||
| 6 months | -38.49% | ||
| Current year | -33.39% |
| 1 week | 226.9 |  | 244.3 |
| 1 month | 226.9 | | 291 |
| Current year | 226.9 | | 391.8 |
| 1 year | 226.9 | | 587.5 |
| 3 years | 217.2 | | 726.9 |
| 5 years | 75 | | 1,000 |
| 10 years | 44 | | 1,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 2013-12-31 | |
| Director of Finance/CFO | - | 2020-11-07 | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2013-12-31 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 1983-05-04 |
| Director/Board Member | 45 | 1999-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | -4.05% | -55.23% | -28.94% | 37.7M | |
| -1.12% | -5.49% | +60.19% | +112.43% | 1,060B | |
| -1.57% | -0.60% | +50.33% | +59.86% | 651B | |
| -1.81% | -1.41% | +24.07% | +75.98% | 465B | |
| -1.17% | -2.10% | +38.61% | +40.43% | 365B | |
| -2.00% | -1.35% | +22.22% | +38.92% | 300B | |
| -0.98% | +0.53% | +2.04% | +12.13% | 258B | |
| -0.76% | +0.75% | +51.75% | +70.45% | 238B | |
| -3.18% | -0.30% | -17.23% | -53.79% | 210B | |
| +0.52% | +3.78% | +30.67% | +93.68% | 184B | |
| Average | -1.22% | -0.21% | +20.74% | +42.11% | 373.04B | |
| Weighted average by Cap. | -1.36% | -1.46% | +38.43% | +65.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827M 6.72M 5.77M 5.4M 4.95M 9.32M 642M 9.35M 63.97M 25.01M 324M 25.24M 24.69M 1.07B | 665M 5.4M 4.64M 4.34M 3.98M 7.49M 516M 7.51M 51.41M 20.1M 260M 20.28M 19.84M 861M |
| Net income | 42.33M 344K 295K 276K 253K 477K 32.85M 478K 3.27M 1.28M 16.56M 1.29M 1.26M 54.79M | 35.02M 285K 244K 229K 209K 394K 27.18M 396K 2.71M 1.06M 13.7M 1.07M 1.05M 45.33M |
| Net Debt | 290M 2.36M 2.03M 1.9M 1.74M 3.27M 225M 3.28M 22.46M 8.78M 114M 8.86M 8.67M 376M | 302M 2.45M 2.11M 1.97M 1.81M 3.4M 234M 3.41M 23.36M 9.13M 118M 9.22M 9.02M 391M |
Employees
563
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | BDT 228.40 | +0.35% | 46,595 |
| 26-08-25 | BDT 227.60 | -0.13% | 63,595 |
| 26-08-24 | BDT 227.90 | -3.19% | 103,007 |
| 26-08-23 | BDT 235.40 | -3.01% | 124,381 |
| 26-08-20 | BDT 242.70 | +5.06% | 189,184 |
- Stock Market
- Stocks
- ORIONINFU Stock
Select your edition
All financial news and data tailored to specific country editions
